These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6967605)

  • 1. Anticonvulsant effects of acute and chronic phenytoin treatment in Rana pipiens.
    Johnson SW; Riker WK
    Proc West Pharmacol Soc; 1980; 23():413-7. PubMed ID: 6967605
    [No Abstract]   [Full Text] [Related]  

  • 2. A comparative study of the effects of phenytoin and phenobarbital on electrically induced maximal seizures in frogs and mice.
    Johnson SW; Riker WK
    J Pharmacol Exp Ther; 1982 Apr; 221(1):132-8. PubMed ID: 6977640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anticonvulsant activity of delta9-tetrahydrocannabilol and its 11-hydroxy and 8alpha, 11-dihydroxy metabolites in the frog.
    Karler R; Cely W; Turkanis SA
    Res Commun Chem Pathol Pharmacol; 1974 Nov; 9(3):441-52. PubMed ID: 4548551
    [No Abstract]   [Full Text] [Related]  

  • 4. Anticonvulsant activity, adverse effects and plasma levels of conventional antiepileptic drugs at different times after single administration.
    Borowicz KK; Gasior M; Kocki T; Błaszczak P; Turski WA; Kleinrok Z; Czuczwar SJ
    Pol J Pharmacol; 1997; 49(1):69. PubMed ID: 9431558
    [No Abstract]   [Full Text] [Related]  

  • 5. Increased anticonvulsant effect of phenytoin in aging BDF1 mice.
    Kitani K; Masuda Y; Sato Y; Kanai S; Ohta M; Nokubo M
    J Pharmacol Exp Ther; 1984 Apr; 229(1):231-6. PubMed ID: 6707939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a synergistic interaction between phenytoin and phenobarbital in experimental animals.
    Masuda Y; Utsui Y; Shiraishi Y; Karasawa T; Yoshida K; Shimizu M
    J Pharmacol Exp Ther; 1981 Jun; 217(3):805-11. PubMed ID: 7230008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats.
    Della Paschoa OE; Mandema JW; Voskuyl RA; Danhof M
    J Pharmacol Exp Ther; 1998 Feb; 284(2):460-6. PubMed ID: 9454785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticonvulsant activity of reaction products of 5,5-diphenylhydantoin with substituted methylene bromides.
    Usifoh CO
    Arch Pharm (Weinheim); 2001 Nov; 334(11):366-8. PubMed ID: 11822175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of anticonvulsant effects of diphenylhydantoin by sulfonamides in the rat.
    Sharma KK; Sen P; Bapna JS; Khanna T
    Arch Int Pharmacodyn Ther; 1978 Dec; 236(2):266-75. PubMed ID: 747473
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of substitution on anticonvulsant activity of some 5,5-diphenylhydantoin derivatives.
    Lange J; Lapszewicz J
    Acta Pol Pharm; 1990; 47(1-2):31-4. PubMed ID: 12959256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-histidine is a beneficial adjuvant for antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Kamiński RM; Zółkowska D; Kozicka M; Kleinrok Z; Czuczwar SJ
    Amino Acids; 2004 Feb; 26(1):85-9. PubMed ID: 14752621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of chronic treatment with H1 receptor antagonists on the anticonvulsant activity of antiepileptic drugs.
    Swiader M; Chwalczuk K; Wielosz M; Czuczwar SJ
    Pol J Pharmacol; 2001; 53(1):93-6. PubMed ID: 11785920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticonvulsant and neurotoxicity profile of Nardostachys jatamansi in rats.
    Rao VS; Rao A; Karanth KS
    J Ethnopharmacol; 2005 Dec; 102(3):351-6. PubMed ID: 16095854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticonvulsant efficacy and adverse effects of phenytoin during chronic treatment in amygdala-kindled rats.
    Rundfeldt C; Löscher W
    J Pharmacol Exp Ther; 1993 Jul; 266(1):216-23. PubMed ID: 8331559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Imperatorin enhances the protective activity of conventional antiepileptic drugs against maximal electroshock-induced seizures in mice.
    Luszczki JJ; Glowniak K; Czuczwar SJ
    Eur J Pharmacol; 2007 Nov; 574(2-3):133-9. PubMed ID: 17651727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reassessment of the anticonvulsant activity of alpha, alpha-diphenyl-succinimide.
    Jones MF; Jones GL; Amato RJ; Peyton GA; Wimbish GH
    Proc West Pharmacol Soc; 1980; 23():171-4. PubMed ID: 7403123
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological properties of N-aminodiphenylhydantoin, a new hydantoin derivative with anticonvulsant activity.
    Rump S; Ilczuk I; Rabsztyn T; Walczyna K
    Pharmazie; 1981 Nov; 36(11):780-1. PubMed ID: 7323129
    [No Abstract]   [Full Text] [Related]  

  • 18. 1-Methyl-1,2,3,4-tetrahydroisoquinoline enhances the anticonvulsant action of carbamazepine and valproate in the mouse maximal electroshock seizure model.
    Luszczki JJ; Antkiewicz-Michaluk L; Czuczwar SJ
    Neuropharmacology; 2006 Feb; 50(2):133-42. PubMed ID: 16153667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p-Aminobenzene sulphonyl morpholine, compound 82/208 a new anticonvulsant agent.
    Dua PR; Ahuja P; Anand N
    Indian J Exp Biol; 1994 Oct; 32(10):729-31. PubMed ID: 7821984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epileptiform seizures in domestic fowl. VII. Plasma phenytoin concentrations and anticonvulsant activity.
    Davis HL; Johnson DD; Crawford RD
    Can J Physiol Pharmacol; 1978 Apr; 56(2):310-5. PubMed ID: 638884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.